View in EDS

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.

Saved in:
Bibliographic Details
Title: Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.
Authors: Camidge DR; University of Colorado Cancer Center, Aurora, CO., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Ahn MJ; Samsung Medical Center, Seoul, South Korea., Yang JCH; National Taiwan University Hospital, Taipei, Taiwan., Han JY; National Cancer Center, Goyang, South Korea., Hochmair MJ; Department of Respiratory and Critical Care Medicine, Krankenhaus Nord-Klinik Floridsdorf, Vienna, Austria., Lee KH; Chungbuk National University Hospital, Cheongju, South Korea., Delmonte A; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy., García Campelo MR; Complejo Hospitalario Universitario A Coruna, Coruna, Spain., Kim DW; Seoul National University Hospital, Seoul, South Korea., Griesinger F; Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany., Felip E; Vall d'Hebron University Hospital, Barcelona, Spain., Califano R; The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Spira A; Virginia Cancer Specialists and US Oncology Research, The Woodlands, TX., Gettinger SN; Yale Cancer Center, New Haven, CT., Tiseo M; University Hospital of Parma, Parma, Italy., Lin HM; Millennium Pharmaceuticals, Cambridge, MA., Gupta N; Millennium Pharmaceuticals, Cambridge, MA., Hanley MJ; Millennium Pharmaceuticals, Cambridge, MA., Ni Q; Millennium Pharmaceuticals, Cambridge, MA., Zhang P; Millennium Pharmaceuticals, Cambridge, MA., Popat S; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 01; Vol. 38 (31), pp. 3592-3603. Date of Electronic Publication: 2020 Aug 11.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32780660
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Camidge+DR%22">Camidge DR</searchLink>; University of Colorado Cancer Center, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Kim+HR%22">Kim HR</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+MJ%22">Ahn MJ</searchLink>; Samsung Medical Center, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Yang+JCH%22">Yang JCH</searchLink>; National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Han+JY%22">Han JY</searchLink>; National Cancer Center, Goyang, South Korea.<br /><searchLink fieldCode="AU" term="%22Hochmair+MJ%22">Hochmair MJ</searchLink>; Department of Respiratory and Critical Care Medicine, Krankenhaus Nord-Klinik Floridsdorf, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Chungbuk National University Hospital, Cheongju, South Korea.<br /><searchLink fieldCode="AU" term="%22Delmonte+A%22">Delmonte A</searchLink>; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22García+Campelo+MR%22">García Campelo MR</searchLink>; Complejo Hospitalario Universitario A Coruna, Coruna, Spain.<br /><searchLink fieldCode="AU" term="%22Kim+DW%22">Kim DW</searchLink>; Seoul National University Hospital, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Griesinger+F%22">Griesinger F</searchLink>; Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Felip+E%22">Felip E</searchLink>; Vall d'Hebron University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Califano+R%22">Califano R</searchLink>; The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Spira+A%22">Spira A</searchLink>; Virginia Cancer Specialists and US Oncology Research, The Woodlands, TX.<br /><searchLink fieldCode="AU" term="%22Gettinger+SN%22">Gettinger SN</searchLink>; Yale Cancer Center, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Tiseo+M%22">Tiseo M</searchLink>; University Hospital of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Lin+HM%22">Lin HM</searchLink>; Millennium Pharmaceuticals, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Gupta+N%22">Gupta N</searchLink>; Millennium Pharmaceuticals, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Hanley+MJ%22">Hanley MJ</searchLink>; Millennium Pharmaceuticals, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Ni+Q%22">Ni Q</searchLink>; Millennium Pharmaceuticals, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Zhang+P%22">Zhang P</searchLink>; Millennium Pharmaceuticals, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Popat+S%22">Popat S</searchLink>; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2020 Nov 01; Vol. 38 (31), pp. 3592-3603. <i>Date of Electronic Publication: </i>2020 Aug 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32780660
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.20.00505
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3592
    Titles:
      – TitleFull: Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Camidge DR
      – PersonEntity:
          Name:
            NameFull: Kim HR
      – PersonEntity:
          Name:
            NameFull: Ahn MJ
      – PersonEntity:
          Name:
            NameFull: Yang JCH
      – PersonEntity:
          Name:
            NameFull: Han JY
      – PersonEntity:
          Name:
            NameFull: Hochmair MJ
      – PersonEntity:
          Name:
            NameFull: Lee KH
      – PersonEntity:
          Name:
            NameFull: Delmonte A
      – PersonEntity:
          Name:
            NameFull: García Campelo MR
      – PersonEntity:
          Name:
            NameFull: Kim DW
      – PersonEntity:
          Name:
            NameFull: Griesinger F
      – PersonEntity:
          Name:
            NameFull: Felip E
      – PersonEntity:
          Name:
            NameFull: Califano R
      – PersonEntity:
          Name:
            NameFull: Spira A
      – PersonEntity:
          Name:
            NameFull: Gettinger SN
      – PersonEntity:
          Name:
            NameFull: Tiseo M
      – PersonEntity:
          Name:
            NameFull: Lin HM
      – PersonEntity:
          Name:
            NameFull: Gupta N
      – PersonEntity:
          Name:
            NameFull: Hanley MJ
      – PersonEntity:
          Name:
            NameFull: Ni Q
      – PersonEntity:
          Name:
            NameFull: Zhang P
      – PersonEntity:
          Name:
            NameFull: Popat S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2020 Nov 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 31
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1